On Thursday, Shares of Chesapeake Energy Corporation (NYSE:CHK), added 2.23% and closed at $6.43 in the last trading session. The last trading range of the stock ranges between $6.04 and $6.55. Chesapeake Energy Corporation engages in the acquisition, exploration, and development of properties for the production of oil, natural gas, and natural gas liquids (NGL) from underground reservoirs in the United States. It operates in two segments, Exploration and Production; and Marketing, Gathering, and Compression. The company holds interests in natural gas resource plays, counting the Haynesville/Bossier Shales in northwestern Louisiana and East Texas; the Marcellus Shale in the northern Appalachian Basin in Pennsylvania; and the Barnett Shale in the Fort Worth Basin of north-central Texas. It also holds interests in liquids-rich resource plays, such as the Eagle Ford Shale in South Texas; the Utica Shale in Ohio and Pennsylvania; the Anadarko Basin in northwestern Oklahoma and the Texas Panhandle; and the Niobrara Shale in the Powder River Basin in Wyoming. The company owns interests in about 32,400 oil and natural gas wells. As of December 31, 2015, it had estimated proved reserves of 1.504 billion barrels of oil equivalent. The company also provides oil, natural gas, and NGL marketing services comprising commodity price structuring, securing and negotiating gathering, hauling, processing and transportation, contract administration, and nomination services for Chesapeake-operated wells; and marketing services for third-party producers, in addition to designs, engineers, fabricates, installs, and sells natural gas compression units, accessories, and equipment used in the production, treatment, and processing of oil and natural gas.
Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA), jumped 0.36% and closed at $44.28 in the last trading session. The last trading range of the stock ranges between $43.80 and $44.64. The company’s Market capitalization is $45.95 Billion with the total Outstanding Shares of 1.01 Billion. Teva Pharmaceutical Industries Ltd., (NYSE and TASE: TEVA) recently declared the launch of RAJANITM (drospirenone, ethinyl estradiol and levomefolate calcium tablets, 3 mg/0.02 mg/0.451 mg and levomefolate calcium tablets, 0.451 mg) in the United States. RAJANITM, the generic equivalent of Beyaz®1, is an oral contraceptive, available in a 28-day blister pack dispenser, for use by women to:
treat symptoms of premenstrual dysphoric disorder (PMDD) in women choosing to use an oral contraceptive for contraception;
treat moderate acne for women at least 14 years old if the patient desires an oral contraceptive for birth control; and
raise folate levels in women who choose to use an oral contraceptive for contraception.
Teva is committed to strengthening its generics business through continued investment in complex, high-quality products. With nearly 600 generic medicines available, Teva has the leading portfolio of FDA-approved generic products on the market. This product enhances Teva’s already comprehensive oral contraceptive portfolio.
TD Ameritrade Holding Corp. (NASDAQ:AMTD), subtract -0.03% and closed at $35.69 in the last trading session. The last trading range of the stock ranges between $34.73 and $35.80. During the 52-week trading session the minimum price at which share price traded, registered at $24.88 and reached to max level of $37.90. TD Ameritrade Holding Corporation (AMTD) will hold its quarterly conference call to discuss fiscal fourth quarter and year-end results, and related matters, on Tuesday, Oct. 25, 2016 at 8:30 a.m. EDT (7:30 a.m. CDT).
Conference Call Details:
Participants may listen to the conference call by dialing 877-648-7976.
A replay of the phone call will be available by dialing 855-859-2056 and entering the Conference ID 69450485 starting at 11:30 a.m. EDT (10:30 a.m. CDT) on Oct. 25, 2016. The replay will be available until 11:59 p.m. EDT (10:59 a.m. CDT) on Nov. 1, 2016.